Literature DB >> 33835423

Posttranslational modification of pyruvate kinase type M2 (PKM2): novel regulation of its biological roles to be further discovered.

Shutao Zheng1,2, Qing Liu1,2, Tao Liu3, Xiaomei Lu4,5.   

Abstract

PKM2, pyruvate kinase type M2, has been shown to play a key role in aerobic glycolysis and to regulate the malignant behaviors of cancer cells. Recently, PKM2 has been revealed to hold dual metabolic and nonmetabolic roles. Working as both a pyruvate kinase with catalytic activity and a protein kinase that phosphorylates its substrates, PKM2 stands at the crossroads of glycolysis and tumor growth. Recently, it was revealed that the catalytic activity of PKM2 can be regulated by its posttranslational modification (PTM). Several PTM types, including phosphorylation, methylation, acetylation, oxidation, hydroxylation, succinylation, and glycylation, have been gradually identified on different amino acid residues of the PKM2 coding sequence. In this review, we highlight the recent advancements in understanding PKM2 PTMs and the regulatory roles conferred by PTMs during anaerobic glycolysis in tumors.

Entities:  

Keywords:  Acetylation; Anaerobic glycolysis; Methylation; PKM2; Phosphorylation; Posttranslational modification (PTM); Warburg effect

Year:  2021        PMID: 33835423     DOI: 10.1007/s13105-021-00813-0

Source DB:  PubMed          Journal:  J Physiol Biochem        ISSN: 1138-7548            Impact factor:   4.158


  61 in total

1.  CARM1 suppresses de novo serine synthesis by promoting PKM2 activity.

Authors:  Tharindumala Abeywardana; Myungeun Oh; Lei Jiang; Ying Yang; Mei Kong; Jikui Song; Yanzhong Yang
Journal:  J Biol Chem       Date:  2018-08-21       Impact factor: 5.157

2.  Inhibition of pyruvate kinase M2 by reactive oxygen species contributes to cellular antioxidant responses.

Authors:  Dimitrios Anastasiou; George Poulogiannis; John M Asara; Matthew B Boxer; Jian-kang Jiang; Min Shen; Gary Bellinger; Atsuo T Sasaki; Jason W Locasale; Douglas S Auld; Craig J Thomas; Matthew G Vander Heiden; Lewis C Cantley
Journal:  Science       Date:  2011-11-03       Impact factor: 47.728

Review 3.  Sumoylation on its 25th anniversary: mechanisms, pathology, and emerging concepts.

Authors:  Arda B Celen; Umut Sahin
Journal:  FEBS J       Date:  2020-05-01       Impact factor: 5.542

4.  SIRT6 deacetylates PKM2 to suppress its nuclear localization and oncogenic functions.

Authors:  Abhishek Bhardwaj; Sanjeev Das
Journal:  Proc Natl Acad Sci U S A       Date:  2016-01-19       Impact factor: 11.205

5.  Site-specific characterization and quantitation of N-glycopeptides in PKM2 knockout breast cancer cells using DiLeu isobaric tags enabled by electron-transfer/higher-energy collision dissociation (EThcD).

Authors:  Zhengwei Chen; Qing Yu; Ling Hao; Fabao Liu; Jillian Johnson; Zichuan Tian; W John Kao; Wei Xu; Lingjun Li
Journal:  Analyst       Date:  2018-05-29       Impact factor: 4.616

6.  No evidence for a shift in pyruvate kinase PKM1 to PKM2 expression during tumorigenesis.

Authors:  Katharina Bluemlein; Nana-Maria Grüning; René G Feichtinger; Hans Lehrach; Barbara Kofler; Markus Ralser
Journal:  Oncotarget       Date:  2011-05

7.  Small ubiquitin-like modifier 1 modification of pyruvate kinase M2 promotes aerobic glycolysis and cell proliferation in A549 human lung cancer cells.

Authors:  Shuxian An; Liangqian Huang; Ping Miao; Liang Shi; Mengqin Shen; Xiaoping Zhao; Jianjun Liu; Gang Huang
Journal:  Onco Targets Ther       Date:  2018-04-13       Impact factor: 4.147

8.  Promiscuity and specificity of eukaryotic glycosyltransferases.

Authors:  Ansuman Biswas; Mukund Thattai
Journal:  Biochem Soc Trans       Date:  2020-06-30       Impact factor: 5.407

Review 9.  Role of O-Linked N-Acetylglucosamine Protein Modification in Cellular (Patho)Physiology.

Authors:  John C Chatham; Jianhua Zhang; Adam R Wende
Journal:  Physiol Rev       Date:  2020-07-30       Impact factor: 37.312

View more
  1 in total

1.  Sulforaphane diminishes moonlighting of pyruvate kinase M2 and interleukin 1β expression in M1 (LPS) macrophages.

Authors:  Sheyda Bahiraii; Martin Brenner; Fangfang Yan; Wolfram Weckwerth; Elke H Heiss
Journal:  Front Immunol       Date:  2022-08-02       Impact factor: 8.786

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.